ARTICLE | Clinical News
Columbia Labs completes Phase III
May 9, 2000 7:00 AM UTC
COB completed enrollment in a placebo-controlled Phase III study of its Advantage-S bioadhesive system to deliver nonoxynol-9 to prevent HIV transmission in high-risk women. Data will be presented at ...